These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 23598969

  • 1. Moderators of outcome in late-life depression: a patient-level meta-analysis.
    Nelson JC, Delucchi KL, Schneider LS.
    Am J Psychiatry; 2013 Jun; 170(6):651-9. PubMed ID: 23598969
    [Abstract] [Full Text] [Related]

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 3. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH, Robbins-Welty GA, Smagula SF, Karp JF, Butters MA, Lenze EJ, Mulsant BH, Blumberger D, Anderson SJ, Dew MA, Lotrich F, Aizenstein HJ, Diniz BS, Reynolds CF.
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.
    Nelson JC, Delucchi K, Schneider LS.
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):558-67. PubMed ID: 18591576
    [Abstract] [Full Text] [Related]

  • 5. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
    Nelson JC, Delucchi K, Schneider LS.
    Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
    [Abstract] [Full Text] [Related]

  • 6. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
    Habra ME, Baker B, Frasure-Smith N, Swenson JR, Koszycki D, Butler G, van Zyl LT, Lespérance F.
    J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
    [Abstract] [Full Text] [Related]

  • 7. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
    Sung SC, Wisniewski SR, Balasubramani GK, Zisook S, Kurian B, Warden D, Trivedi MH, Rush AJ, CO-MED Study Team.
    Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [Abstract] [Full Text] [Related]

  • 9. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [Abstract] [Full Text] [Related]

  • 10. Treatment of depression--newer pharmacotherapies.
    Mulrow CD, Williams JW, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.
    Psychopharmacol Bull; 1998 Apr; 34(4):409-795. PubMed ID: 10513454
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 12. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.
    JAMA; 2007 Apr 18; 297(15):1683-96. PubMed ID: 17440145
    [Abstract] [Full Text] [Related]

  • 13. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.
    Zimmerman M, Holst CG, Clark HL, Multach M, Walsh E, Rosenstein LK, Gazarian D.
    CNS Drugs; 2016 Dec 18; 30(12):1209-1218. PubMed ID: 27541608
    [Abstract] [Full Text] [Related]

  • 14. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES, Howard C, Khan DA, Carmody TJ.
    Psychosomatics; 2012 Dec 18; 53(1):75-80. PubMed ID: 22221724
    [Abstract] [Full Text] [Related]

  • 15. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G, Frare F, Toni C, Ruffolo G, Torti C.
    Neuropsychobiology; 2002 Dec 18; 46(3):145-9. PubMed ID: 12422062
    [Abstract] [Full Text] [Related]

  • 16. Late-onset major depression: clinical and treatment-response variability.
    Driscoll HC, Basinski J, Mulsant BH, Butters MA, Dew MA, Houck PR, Mazumdar S, Miller MD, Pollock BG, Stack JA, Schlernitzauer MA, Reynolds CF.
    Int J Geriatr Psychiatry; 2005 Jul 18; 20(7):661-7. PubMed ID: 16021664
    [Abstract] [Full Text] [Related]

  • 17. Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial.
    Salardini E, Zeinoddini A, Mohammadinejad P, Khodaie-Ardakani MR, Zahraei N, Zeinoddini A, Akhondzadeh S.
    J Psychiatr Res; 2016 Apr 18; 75():24-30. PubMed ID: 26800392
    [Abstract] [Full Text] [Related]

  • 18. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ, Wisniewski SR, Zisook S, Fava M, Sung SC, Haley CL, Chan HN, Gilmer WS, Warden D, Nierenberg AA, Balasubramani GK, Gaynes BN, Trivedi MH, Hollon SD.
    Psychol Med; 2012 Jun 18; 42(6):1131-49. PubMed ID: 22008447
    [Abstract] [Full Text] [Related]

  • 19. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.
    J Clin Psychiatry; 2011 Oct 18; 72(10):1405-12. PubMed ID: 21367355
    [Abstract] [Full Text] [Related]

  • 20. Placebo response and antidepressant response.
    Alexopoulos GS, Kanellopoulos D, Murphy C, Gunning-Dixon F, Katz R, Heo M.
    Am J Geriatr Psychiatry; 2007 Feb 18; 15(2):149-58. PubMed ID: 17272735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.